The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coates, J. A., Cammack, N., Jenkinson, H. J., Jowett, A. J., Jowett, M. I., Pearson, B. A., Penn, C. R., Rouse, P. L., Viner, K. C., & Cameron, J. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.733 · Cited by 240
Cited by
Antiviral effect of catechins in green tea on influenza virus
Song, J.-M., Lee, K.-H., & Seong, B.-L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.06.010 · Cited by 654
Friedman, M. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600173 · Cited by 641
Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12009 · Cited by 559
Flavonoids: Promising Natural Compounds against Viral Infections
Zakaryan, H., Arabyan, E., Oo, A., & Zandi, K. (2017) · Archives of Virology · doi:10.1007/s00705-017-3417-y · Cited by 534
Medicinal Benefits of Green Tea: Part I. Review of Noncancer Health Benefits
Cooper, R., Morré, D. J., & Morré, D. M. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.521 · Cited by 360
Metadata
- Authors
- Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y., & Shimamura, T.
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 53
- Issue
- 1
- Pages
- 19-34
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W1968906564
- Cited by
- 225
- References
- 1
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). https://app.cochat.ai/papers/10.1016/s0166-3542(01)00189-9
- The paper
- Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y., & Shimamura, T. (2002). Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Research. https://doi.org/10.1016/s0166-3542(01)00189-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.